Parenteral nutrition is a high-alert medication containing many individual pharmaceutical ingredients. Despite being used in a wide variety of clinical settings and involving a complex drug use process, institutions often use different methods to achieve the same end result. In September 2011, A.S.P.E.N convened a parenteral nutrition safety summit to identify and outline the processes surrounding the use of parenteral nutrition in order to ensure the safe preparation and use of parenteral nutrition. This program will focus on the aspects of preparing parenteral nutrition, particularly the implications of USP <797> on parenteral nutrition compounding, and the advantages and disadvantages of compounding versus standardized commercial parenteral nutrition products.

Objectives
1. Describe USP Chapter <797> as it relates specifically to desired parenteral nutrition sterile compounding practices
2. List desired strategies to manage PN component shortages through high-risk level compounding
3. Discuss the pros and cons of standardized commercial parenteral nutrition (PN) versus compounded PN.
4. Assess where the use of standardized commercial PN may be instituted including patient populations and situations/scenarios.


Recording will be available by late-April